The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Revealing the mysteries within microbial genomes
Pharma & Human Health

Revealing the mysteries within microbial genomes

SEP 1, 2024
Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods
Biotics and Supplements

Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

SEP 1, 2024
Researchers develop probiotic to ameliorate ulcerative colitis
Biotics and Supplements

Researchers develop probiotic to ameliorate ulcerative colitis

SEP 1, 2024
Mining the microbiome: Uncovering new antibiotics inside the human gut
Infectious Disease & AMR

Mining the microbiome: Uncovering new antibiotics inside the human gut

AUG 27, 2024
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Finance

Ancilia Biosciences Announces Closing of $4.2 Million Financing

JUL 18, 2024
New findings may fix the replicability crisis in microbiome research
Pharma & Human Health

New findings may fix the replicability crisis in microbiome research

JUL 10, 2024
MIT engineers find a way to protect microbes from extreme conditions
Animal Health

MIT engineers find a way to protect microbes from extreme conditions

JUL 9, 2024
SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women
Finance

SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women

JUL 1, 2024
Lallemand Health Solutions: Pioneering Microbiome Innovations with Expert’Biome™ CDMO
Finance

Lallemand Health Solutions: Pioneering Microbiome Innovations with Expert’Biome™ CDMO

JUN 4, 2024
AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet
Gastrointestinal

AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet

MAY 29, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024